Titre:
  • European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment–Update 2023
Auteur:Stratigos, Alexander; Garbe, Claus; Dessinioti, Clio; Lebbe, Céleste; van Akkooi, Alexander A.C.J.; Bataille, Véronique; Bastholt, Lars; Dreno, Brigitte; Dummer, Reinhard; Fargnoli, Maria Maria Concetta M.C.; Forsea, Ana-Maria; Harwood, Catherine Anne; Hauschild, Axel; Hoeller, Christoph; Kandolf-Sekulovic, Lidija; Kaufmann, Roland; Kelleners-Smeets, Nicole WJ; Lallas, Aimilios; Leiter, Ulrike; Malvehy, Josep; Del Marmol, Véronique; Moreno-Ramirez, David; Pellacani, Giovanni; Peris, Ketty; Saiag, Philippe; Tagliaferri, Luca; Trakatelli, Myrto Georgia; Ioannides, Demetrios; Vieira, Ricardo; Zalaudek, Iris; Arenberger, Petr; Eggermont, Alexander A.M.M.; Rocken, Martin; Grob, Jean Jacques; Lorigan, Paul
Informations sur la publication:European journal of cancer, 193, 113252
Statut de publication:Publié, 2023-11
Sujet CREF:Cancérologie
Mots-clés:Adjuvant
Anti-PD-1 antibody
Cemiplimab
Cutaneous squamous cell carcinoma
Follow-up
Locally advanced
Metastatic
Radiotherapy
Surgical excision
Treatment
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0959-8049
info:doi/10.1016/j.ejca.2023.113252
info:pii/S0959804923003544
info:scp/85170715478
info:pmid/37708630